In this study published in Vaccine ... literature, FDA documents, epidemiological databases, and manufacturer data were searched to create a decision-analytical model of RSV over a 2-year timeframe.

"Their decision was based on the latest available evidence at that time, including how long protection lasts and how common RSV infection is within different age groups, and they concluded that there ...

This summer, GSK cut its yearly vaccine sales projection on the back of a narrowed recommendation for adult respiratory syncytial virus (RSV) vaccines from the Centers for Disease Control and ...

New Covid-19 shots are on their way, leaving plenty of time to get them before respiratory illness season this fall.

Almost all children will get RSV during their first two years, but each year up to 80,000 children are hospitalized due to it. Now, a new FDA approved vaccine can protect your baby — even before ...

The U.S. Food and Drug Administration on Friday authorized the updated version of the protein-based Novavax Covid-19 vaccine for use in people 12 and older. Advertisement One week ago, the FDA ...

but the FDA should engage more effectively as well. The decision prolongs — probably for a decade — the availability of much-needed treatments. It is harmful, for all the veterans and millions ...

There are certain types of clinical studies that would not support exclusivity, and Liquidia argues this includes the study that the FDA has based its decision on. "FDA exceeded its statutory ...

Novavax NVAX announced that the FDA granted emergency use authorization (EUA) to an updated version of its protein-based COVID-19 vaccine for individuals aged 12 years and older. Following this ...

The decision means the deal’s fate will almost certainly not be decided until after the US election on November 5. The extension is a new twist in an almost year-long saga that has become ...

RSV is a common cause of coughs and colds 🤧 The RSV vaccine is being rolled out on the NHS in England, Wales and Northern Ireland. The vaccination programme aims to protect new born babies and ...